NCT06592937

Brief Summary

We merged the dataset of three large observational studies of invasive ventilation in critically ill patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,270

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2024

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

7 months

First QC Date

July 22, 2024

Last Update Submit

September 10, 2024

Conditions

Keywords

ICUInvasive ventilationRespiratory supportMortality

Outcome Measures

Primary Outcomes (1)

  • ICU morality

    any mortality occurred during ICU stay

    ICU stay, anticipated average 15 days

Secondary Outcomes (1)

  • Mechanical Power

    During the first 7 days of invasive ventilation

Study Arms (1)

Patients receiving invasive ventilation

Patients receiving invasive ventilation, included in PRoVENT, PRoVENT-iMiC, and ENIO

Other: Invasive ventilation

Interventions

Invasive ventilation and respiratory support

Patients receiving invasive ventilation

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

PROVENT, PROVENT-iMiC and ENIO included various types of patients, receiving ventilation for different reasons. For this first analysis we will select patients receiving invasive ventilation for acute brain injury.

All patients in the PRIME database are eligible for participation in the initial analysis presented here. We will exclude patients receiving ventilation fir another reason than acute brain injury.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Amsterdam, Netherlands

Location

MeSH Terms

Interventions

Noninvasive Ventilation

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Marcus J Schultz, Prof

    Amsterdam UMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr

Study Record Dates

First Submitted

July 22, 2024

First Posted

September 19, 2024

Study Start

January 1, 2024

Primary Completion

July 26, 2024

Study Completion

July 26, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Notably, after this initial analysis of PRIME, the database is available for post-hoc analysis.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
After our first pubblication (next six months) and they will remain available for ever
Access Criteria
For this, interested investigators will have to provide a detailed analysis plan, containing a testable hypothesis, clearly described endpoints and an analysis plan. After approval, investigators will be provided with a mock database that will allow them to write an analysis script in R. PROVE network investigators will then run the script on the PRIME database and provide the investigators with the results. Any publication from an additional analysis must follow the rules for publication denoted by the PROVE network
More information

Locations